ERBA Diagnostics, Inc. provided earnings guidance for the year ended December 31, 2012. For the period, the company expects revenues of approximately $19,500,000 compared to revenues of $16,759,773 for the year ended December 31, 2011. Net loss of approximately $1,100,000 compared to net loss of $3,297,343 for the year ended December 31, 2011.
ERBA Diagnostics, Inc.
Equities
ERBA
US29490B1017
Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | |
---|---|---|
-6.58% | 180B | |
-3.56% | 106B | |
-5.34% | 67.55B | |
-6.10% | 46.11B | |
+13.83% | 45.79B | |
+2.58% | 41.61B | |
+19.68% | 31.07B | |
+11.40% | 24.77B | |
-5.50% | 24.27B |